Screening for thyroid cancer: US preventive services task force recommendation statement

JAMA - Journal of the American Medical Association

Volumn 317, Issue 18, 2017, Pages 1882-1887

  Bibbins Domingo, Kirsten ^a   Grossman, David C ^b   Curry, Susan J ^c   Barry, Michael J ^d   Davidson, Karina W ^e   Doubeni, Chyke A ^f   Epling, John W ^g   Kemper, Alex R ^h   Krist, Alex H ^i,j   Kurth, Ann E ^k   Landefeld, C Seth ^l   Mangione, Carol M ^m   Phipps, Maureen G ⁿ   Silverstein, Michael ^o   Simon, Melissa A ^p   Siu, Albert L ^q,r   Tseng, Chien Wen ^s,t  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAISER PERMANENTE   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g VIRGINIA TECH CARILION SCHOOL OF MEDICINE   (United States)

^h DUKE UNIVERSITY   (United States)

ⁱ Fairfax Family Practice Residency   (United States)

^j VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^k YALE UNIVERSITY   (United States)

^l UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ BROWN UNIVERSITY   (United States)

^o BOSTON UNIVERSITY   (United States)

^p NORTHWESTERN UNIVERSITY   (United States)

^q MOUNT SINAI HOSPITAL   (United States)

^r VETERANS AFFAIRS MEDICAL CENTER   (United States)

^s PACIFIC HEALTH RESEARCH AND EDUCATION INSTITUTE   (United States)

^t UNIVERSITY OF HAWAII   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

CANCER SCREENING; DIAGNOSTIC ACCURACY; EARLY CANCER DIAGNOSIS; ECHOGRAPHY; FAMILY HISTORY; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; HYPOPARATHYROIDISM; LYMPH NODE DISSECTION; NECK PALPATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECURRENT LARYNGEAL NERVE PALSY; REVIEW; RISK ASSESSMENT; SURGICAL MORTALITY; THYROID CANCER; THYROIDECTOMY; ADULT; ADVISORY COMMITTEE; AGED; ASYMPTOMATIC DISEASE; FEMALE; MALE; MASS SCREENING; MIDDLE AGED; PRACTICE GUIDELINE; THYROID NEOPLASMS; UNITED STATES; VERY ELDERLY;

ADULT; ADVISORY COMMITTEES; AGED; AGED, 80 AND OVER; ASYMPTOMATIC DISEASES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; THYROID NEOPLASMS; UNITED STATES;

EID: 85019473939     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.4011     Document Type: Review

References (34)

1. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2013. Bethesda, MD: National Cancer Institute; 2016, https://seer .cancer.gov/csr/1975-2013/. Accessed March 9, 2017.
2. Cooper DS, Doherty GM, Haugen BR, et al; American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer [published correction appears in Thyroid. 2010;20(8):942]. Thyroid. 2009;19(11):1167-1214.
3. National Cancer Institute. Cancer stat facts: thyroid cancer. https://seer.cancer.gov/statfacts/html/thyro.html. Accessed March 9, 2017.
4. American Cancer Society. Thyroid cancer risk factors. https://www.cancer.org/cancer/thyroid-cancer/causes-risks-prevention/risk-factors.html. Accessed March 9, 2017.
5. Lin JS, Aiello Bowles EJ, Williams SB, Morrison CC. Screeningfor thyroid cancer:updatedevidence report and systematic review for theUSPreventive Services Task Force. JAMA. doi:10.1001/jama.2017.0562
6. American Cancer Society. Thyroid at a glance. https://cancerstatisticscenter.cancer.org. Accessed March 9, 2017.
7. Lin JS, Aiello Bowles EJ, Williams SB, Morrison CC. Screening for Thyroid Cancer: A Systematic Review for the US Preventive Services Task Force: Evidence Synthesis No. 151. Rockville, MD: Agency for Healthcare Research and Quality; 2017. AHRQ publication 15-05221-EF-1.
8. Brander A, Viikinkoski P, Nickels J, Kivisaari L. Thyroid gland: US screening in a random adult population. Radiology. 1991;181(3):683-687.
9. Brander A, Viikinkoski P, Nickels J, Kivisaari L. Thyroid gland: US screening in middle-aged women with no previous thyroid disease. Radiology. 1989; 173(2):507-510.
10. Kim SJ, Moon WK, Cho N. Sonographic criteria for fine-needle aspiration cytology in a Korean female population undergoing thyroid ultrasound screening. Acta Radiol. 2010;51(5):475-481.
11. Kim JY, Lee CH, Kim SY, et al. Radiologic and pathologic findings of nonpalpable thyroid carcinomas detected by ultrasonography in a medical screening center. J Ultrasound Med. 2008; 27(2):215-223.
12. Davies L,Welch HG. Thyroid cancer survival in the United States: observational data from 1973 to 2005. Arch Otolaryngol Head Neck Surg. 2010;136 (5):440-444.
13. Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients.World J Surg. 2010;34(1):28-35.
14. Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid. 2003;13(4):381-387.
15. Ito Y, Miyauchi A, KiharaM, Higashiyama T, Kobayashi K, Miya A. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24(1):27-34.
16. Oda H, Miyauchi A, Ito Y, et al. Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery. Thyroid. 2016;26(1):150-155.
17. Ito Y, Tomoda C, Uruno T, et al. Needle tract implantation of papillary thyroid carcinoma after fine-needle aspiration biopsy.World J Surg. 2005; 29(12):1544-1549.
18. Abu-Yousef MM, Larson JH, Kuehn DM,Wu AS, Laroia AT. Safety of ultrasound-guided fine needle aspiration biopsy of neck lesions in patients taking antithrombotic/anticoagulant medications. Ultrasound Q. 2011;27(3):157-159.
19. Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab. 2008;93(2):504-515.
20. Iyer NG, Morris LG, Tuttle RM, Shaha AR, Ganly I. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy. Cancer. 2011;117 (19):4439-4446.
21. Hyer S, Kong A, Pratt B, Harmer C. Salivary gland toxicity after radioiodine therapy for thyroid cancer. Clin Oncol (R Coll Radiol). 2007;19(1):83-86.
22. Ish-Shalom S, Durleshter L, Segal E, Nagler RM. Sialochemical and oxidative analyses in radioactive I131-treated patients with thyroid carcinoma. Eur J Endocrinol. 2008;158(5):677-681.
23. Jeong SY, Kim HW, Lee SW, Ahn BC, Lee J. Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre-and postablation scintigraphies and their relation to xerostomia symptoms. Thyroid. 2013;23(5):609-616.
24. Solans R, Bosch JA, Galofré P, et al. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. J Nucl Med. 2001;42(5):738-743.
25. Grewal RK, Larson SM, Pentlow CE, et al. Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation. J Nucl Med. 2009;50(10):1605-1610.
26. Ryu CH, Ryu J, Ryu YM, et al. Administration of radioactive iodine therapy within 1 year after total thyroidectomy does not affect vocal function. J Nucl Med. 2015;56(10):1480-1486.
27. Ahn HS, Kim HJ,Welch HG. Korea's thyroid-cancer "epidemic"-screening and overdiagnosis. N Engl J Med. 2014;371(19):1765-1767.
28. Lee YS, Lim H, Chang HS, Park CS. Papillary thyroid microcarcinomas are different from latent papillary thyroid carcinomas at autopsy. J Korean Med Sci. 2014;29(5):676-679.
29. US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Baltimore, MD: Lippincott Williams & Wilkins; 1996.
30. American Cancer Society. Can thyroid cancer be found early? https://www.cancer.org/cancer/thyroid-cancer/detection-diagnosis-staging/detection.html. Accessed March 9, 2017.
31. American Academy of Family Physicians. Clinical preventive service recommendation: thyroid cancer. http://www.aafp.org/patient-care/clinical-recommendations/all/thyroid.html. 1996. Accessed March 9, 2017.
32. Ridley J, Ischayek A, Dubey V, Iglar K. Adult health checkup: update on the Preventive Care Checklist Form. Can Fam Physician. 2016;62(4): 307-313.
33. Haugen BR, Alexander EK, Bible KC, et al; American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. 2015 American Thyroid Association Management Guidelines for Adult Patients With Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133.
34. Gharib H, Papini E, Garber JR, et al; AACE/ACE/AME Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules-2016 update. Endocr Pract. 2016;22(5):622-639.